Research Keyword: Multi drug resistance, Cancer, Immune system, Reprogramming
A better understanding of complex and dynamic system is essential to enable us to develop therapeutic strategies that bypass MDR, and also effective ways of inhibiting MDR components to increase the efficacy of our current extensively used chemotherapies. In this research, to get real-time MDR reactive information, we will build optimized, customizable 3D microfluidic chips, set up natural conditions, such as healthy cells and reconstructed 3D tumor microenvironments (TME) use super-resolution imaging devices from a world-class imaging cluster lab.
Woojin Lee*, Leehyung Kim, Ruda Lee**. Strategic Review of Germany's LULUCF Policy Development Process: Implications for Korea. Journal of Wetlands Research, 24, 102-114, 2022.
*Internship student(2021.09.01-2021.10.27) in IROAST Research Internship Program **Host professor at Kumamoto University
Ruda Lee, Sho Tanigawa, Yong Il Park, Hoon Kim. Antimetabolite Prodrug Delivery for Non-small Cell Lung Cancer, Korean Society for Biotechnology and Bioengineering Journal, 38: 236-243, 2023
Ruda Lee, Yong Il Park. Exosome detection for early cancer diagnosis. Springer, Handbook of Cancer and Immunology, Sep 2023
https://link.springer.com/referenceworkentry/10.1007/978-3-030-80962-1_326-1
(At the venue) (Group photo)
Ruda Lee, Nanoplatform for constructing new approaches to cancer treatment. Kangwon National University, 2022/03/30, Web.